IL-32γ potentiates tumor immunity in melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-32γ potentiates tumor immunity in melanoma

Published:2020-09-17 Issue:18 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Gruber Thomas^ORCID,Kremenovic Mirela,Sadozai Hassan^ORCID,Rombini Nives,Baeriswyl Lukas,Maibach Fabienne,Modlin Robert L.^ORCID,Gilliet Michel,von Werdt Diego,Hunger Robert E.,Seyed Jafari S. Morteza^ORCID,Parisi Giulia,Abril-Rodriguez Gabriel,Ribas Antoni^ORCID,Schenk Mirjam^ORCID

Funder

Foundation for Experimental Biomedicine Zürich, Switzerland

Stiftung für klinisch-experimentelle Tumorforschung Bern, Switzerland

Helmut Horten Foundation

Swiss National Science Foundation

Wilhelm Sander-Stiftung

NIH grants R01

NIH

Parker Institute for Cancer Immunotherapy

V Foundation-Gil Nickel Family Endowed Fellowship in Melanoma Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/138772/files/pdf

Reference69 articles.

1. Cancer immunotherapy using checkpoint blockade

2. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

3. Elements of cancer immunity and the cancer–immune set point

4. T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection

5. The immune contexture in cancer prognosis and treatment

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study;Nature Communications;2024-09-03

2. IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells;Frontiers in Immunology;2024-08-15

3. GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers;Genome Medicine;2023-11-26

4. Upgrading Melanoma Treatment: Promising Immunotherapies Combinations in the Preclinical Mouse Model;Current Cancer Therapy Reviews;2023-10-12

5. IL-32 as a potential biomarker and therapeutic target in skin inflammation;Frontiers in Immunology;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3